- enrolling by invitationPHASE3
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
This study looks at the long-term effects and safety of a drug called Ralinepag for people with a lung condition called pulmonary arterial hypertension (PAH). It's for those who have already tried Ralinepag in a previous study.
United States · Argentina · Australia - enrolling by invitation
Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension
This study looks at a simple, affordable breath test to help diagnose a serious lung condition called pulmonary hypertension. Researchers want to see if measuring carbon dioxide in your breath can quickly show who might have this condition, potentially leading to earlier treatment.
Germany - active not recruitingPHASE3
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
This study looks at a medicine called riociguat (Adempas) for children aged 6 to 17 with pulmonary arterial hypertension (PAH). The aim is to check if it's safe and works well at different doses to help manage this lung condition.
Colombia · Germany · Hungary - active not recruitingPHASE3
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
This study is testing if a medicine called selexipag can help children aged 2-17 with a serious lung condition called pulmonary hypertension. It aims to see if adding selexipag to their usual treatment can slow down the disease compared to a dummy medicine.
United States · Australia · Belarus - active not recruitingPHASE2
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
This study looks at a new medicine called sotatercept for a specific type of high blood pressure in the lungs (Cpc-PH) linked to heart failure. It's for people who were in a previous study to see how the medicine works long-term and if it's safe.
United States · Belgium · Canada